Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ana M. Metelo"'
Autor:
Haley R. Noonan, Ana M. Metelo, Caramai N. Kamei, Randall T. Peterson, Iain A. Drummond, Othon Iliopoulos
Publikováno v:
Disease Models & Mechanisms, Vol 9, Iss 8, Pp 873-884 (2016)
Patients with von Hippel–Lindau (VHL) disease harbor a germline mutation in the VHL gene leading to the development of several tumor types including clear cell renal cell carcinoma (ccRCC). In addition, the VHL gene is inactivated in over 90% of sp
Externí odkaz:
https://doaj.org/article/e38cdf75c43e40638bacc4db42df2bc9
Autor:
Ana M. Metelo, Agnieszka Jozwik, Le Anh Luong, Delaney Dominey-Foy, Charlotte Graham, Charlotte Attwood, Shafqat Inam, Alan Dunlop, Katy Sanchez, Kirsty Cuthill, Carmel Rice, Matthew Streetly, Trevor Bentley, Bijan Boldajipour, Cesar Sommer, Barbra Sasu, Reuben Benjamin
Publikováno v:
Cancer Research Communications. 2:158-171
Multiple myeloma remains an incurable plasma cell malignancy despite the rapidly evolving treatment landscape. Chimeric antigen receptor T cells targeted against BCMA have recently shown great promise in relapsed refractory multiple myeloma; however,
Autor:
Jing-Ruey Joanna Yeh, Edward Chouchani, Othon Iliopoulos, Andrew M. Intlekofer, Eugene Rhee, Benjamin Olenchock, Kyung Bo Kim, Surendra Punganuru, Michelle L. Kelley, Ana M. Metelo, Yan Liu, Yiyun Zhang, Evanna Mills, Wen Zhou, Iiro Taneli Helenius, Hanumantha Rao Madala
Figure S1-S18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c45f86d5b8c3f5ad72a8f51f0775fb
https://doi.org/10.1158/0008-5472.22426108
https://doi.org/10.1158/0008-5472.22426108
Autor:
Jing-Ruey Joanna Yeh, Edward Chouchani, Othon Iliopoulos, Andrew M. Intlekofer, Eugene Rhee, Benjamin Olenchock, Kyung Bo Kim, Surendra Punganuru, Michelle L. Kelley, Ana M. Metelo, Yan Liu, Yiyun Zhang, Evanna Mills, Wen Zhou, Iiro Taneli Helenius, Hanumantha Rao Madala
Under conditions of inherent or induced mitochondrial dysfunction, cancer cells manifest overlapping metabolic phenotypes, suggesting that they may be targeted via a common approach. Here, we use multiple oxidative phosphorylation (OXPHOS)–competen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3de16a69c1792a4adfa552b1373b28ee
https://doi.org/10.1158/0008-5472.c.6512227.v1
https://doi.org/10.1158/0008-5472.c.6512227.v1
Autor:
Jing-Ruey Joanna Yeh, Edward Chouchani, Othon Iliopoulos, Andrew M. Intlekofer, Eugene Rhee, Benjamin Olenchock, Kyung Bo Kim, Surendra Punganuru, Michelle L. Kelley, Ana M. Metelo, Yan Liu, Yiyun Zhang, Evanna Mills, Wen Zhou, Iiro Taneli Helenius, Hanumantha Rao Madala
Supplemental Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab83fa78c207a301ec2287339af1ad1
https://doi.org/10.1158/0008-5472.22426111
https://doi.org/10.1158/0008-5472.22426111
Autor:
Evanna L. Mills, Benjamin A. Olenchock, Edward T. Chouchani, Surendra R. Punganuru, Wen Zhou, Yan Liu, Ana M. Metelo, Michelle L. Kelley, Andrew M. Intlekofer, Iiro Taneli Helenius, Yiyun Zhang, Othon Iliopoulos, Eugene P. Rhee, Jing-Ruey J. Yeh, Hanumantha Rao Madala, Kyung Bo Kim
Publikováno v:
Cancer Res
Under conditions of inherent or induced mitochondrial dysfunction, cancer cells manifest overlapping metabolic phenotypes, suggesting that they may be targeted via a common approach. Here, we use multiple oxidative phosphorylation (OXPHOS)–competen
Autor:
Piers E.M. Patten, Ana M Metelo, Carlo Scala, Glenda Dickson, Ruby Quartey-Papafio, Maria Almena-Carrasco, Reuben Benjamin, Elisa Peranzoni, Farzin Farzaneh, Orla Stewart, Alan G. Ramsay, Thomas Pertel, Charlotte Graham, Nikolaos Ioannou, Agnieszka Jozwik, Sandra Dupouy, Andrea Pepper
Publikováno v:
Leukemia
Autor:
Othon Iliopoulos, Ana M. Metelo
Publikováno v:
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease ISBN: 9780128138663
Hemangioblastomas (HBs) are vascular tumors of the central nervous system that develop in patients with Von Hippel–Lindau (VHL) disease or sporadically. Loss-of-VHL tumor suppressor gene is a hallmark of both types of HBs. The tumors comprise tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dc1595270b7c1bfb1ca7eb0d8762e4e
https://doi.org/10.1016/b978-0-12-813866-3.00015-1
https://doi.org/10.1016/b978-0-12-813866-3.00015-1
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
The pharmacological action of the V(IV) compound VO(dmpp)2 was previously evaluated in vivo using obese pre-diabetic Zucker rats treated with this compound for four weeks. Besides the promising results regarding biological parameters indicative of in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ef58d0d5eb4384124d7cabcb73c0fda
http://hdl.handle.net/10261/207031
http://hdl.handle.net/10261/207031
Autor:
Caramai N. Kamei, Othon Iliopoulos, Ana M. Metelo, Haley R. Noonan, Randall T. Peterson, Iain A. Drummond
Publikováno v:
Disease Models & Mechanisms, Vol 9, Iss 8, Pp 873-884 (2016)
Disease Models & Mechanisms
Disease Models & Mechanisms
Patients with von Hippel–Lindau (VHL) disease harbor a germline mutation in the VHL gene leading to the development of several tumor types including clear cell renal cell carcinoma (ccRCC). In addition, the VHL gene is inactivated in over 90% of sp